Cancer Catchers

Deans, Alan
October 2001
Bulletin with Newsweek;10/16/2001, Vol. 119 Issue 6297, p12
Details the development of Truscan, a cancer detection device. Conduction of independent trials in six countries to win approval from European regulators; Description of Truscan; Number of individual tests for the accuracy of Truscan. INSET: Healthy profits, by Alan Deans..


Related Articles

  • Cancer Fighter. Gawel, Richard; Konish, Nancy // Electronic Design;06/14/99, Vol. 47 Issue 12, p64B 

    Introduces T-Scan 2000 device used in tumor detection on women breast developed by TransScan Medical Inc. in Ramsey, New Jersey. Description of the T-Scan 200 device; Efficacy and limitations of the device; Condition for the approval of the device; Contact information.

  • Now a Paper Test to Diagnose Cancer. DUTT, ELA // News India Times;3/7/2014, Vol. 45 Issue 10, p10 

    The article reports on the development of Indian-American scientists, led by Sangeeta Bhatia, of an affordable and easy paper test strip to detect cancer.

  • Diagnostics firm sees hope in new test. Somasundaram, Meera // Crain's Chicago Business;03/20/2000, Vol. 23 Issue 12, p66 

    Reports on Chicago, Illinois-based Ampersand Medical Corp.'s development of a device that detects cervical cancer. Potential of improving on the accuracy of the Pap smear; Prevalence of cervical cancer among women in the United States.

  • Diamics lands three-year, $22M-plus contract in China.  // Biomedical Business & Technology;May2007, Vol. 30 Issue 5, p21 

    The article reports on the contract signed by Diamics, a private developer of cancer screening and diagnostics products, with Beijing Jingmin Hospital Group for the use and distribution of its CerCol collector, part of the Pap-Map cervical mapping system, for cervical cancer screening in China....

  • Report: Cancer Diagnostics Market to Grow from $776 mn to $5.3 bn: companiesandmarkets.com.  // Biomedical Market Newsletter;6/19/2011, p1167 

    The article offers information on the report on next generation cancer diagnostic market available on companiesandmarkets.com. It mentions that the market for cancer diagnostics is growing at a compound annual growth rate (CAGR) of 47% and will reach a forecast market size of 5.3 billion dollars...

  • The Trimprob.  // Medeconomics;Nov2003, Vol. 24 Issue 11, p27 

    The Trimprob, a hand-held device for detecting tumors in patients who are fully clothed, could become indispensable in primary care. Designed by physicist Clarbruno Vedruccio, the Trimprob, a baton-shaped unit about 30cm long, works by locating cancerous tissue when swiped across the body. It...

  • New Technologies May Improve Breast Cancer Detection.  // SWE Magazine;2002 Conference, Vol. 48 Issue 5, p136 

    The article reports on the development of new technologies that use infrared light and radio waves used for the detection of breast cancer in the U.S. Researchers found that near infrared light can be used to look at the tumor blood volume and metabolism in the breast. Radiologist Saroja...

  • Improving women's health. Goodman, Michelle // Entrepreneur;May2014, Vol. 42 Issue 5, p72 

    The article discusses medical-device company nVision Medical. Founded by Surbhi Sarna, nVision is developing two catheter-based tools for diagnosing ovarian cancer and blockage of fallopian tubes, respectively. Among investment groups that have provided funding for nVision are Catalyst Health...

  • SENORX GETS 510(K) CLEARANCE FOR SINGLE STEP BIOPSY DEVICE.  // Biotech Equipment Update;Oct2002, p1 

    Reports that medical device company SenoRx Inc. has received 510 (k) clearance from U.S. Food and Drug Administration to market its Single Step breast biopsy device for the diagnosis of breast cancer. Uses of the device; Investors in the company; Other devices for which the company has received...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics